What is the Best Treatment for Microsatellite Instability (MSI)?

Learn about the most effective treatment options for Microsatellite Instability (MSI), including immunotherapy with checkpoint inhibitors.

228 views

Microsatellite Instability (MSI) is often treated with Immunotherapy, specifically with immune checkpoint inhibitors like Pembrolizumab or Nivolumab. These treatments help the immune system recognize and attack cancer cells. Consultation with a healthcare provider for personalized treatment options is recommended.

FAQs & Answers

  1. What is Microsatellite Instability (MSI)? Microsatellite Instability (MSI) is a condition of genetic hypermutability that occurs due to defects in the DNA mismatch repair system, often related to certain cancers.
  2. Which immunotherapy drugs are commonly used to treat MSI? Pembrolizumab and Nivolumab are common immune checkpoint inhibitors used to treat cancers exhibiting Microsatellite Instability.
  3. How does immunotherapy help treat MSI cancers? Immunotherapy helps by enabling the immune system to better recognize and attack cancer cells that exhibit Microsatellite Instability.

Watch More

For more insights on immunotherapy and advanced cancer treatments, explore our related videos covering checkpoint inhibitors, personalized oncology therapies, and managing colorectal and other MSI-related cancers.

  1. How Is Microsatellite Instability (MSI) Treated? Effective Immunotherapy Options Explained Learn how MSI-high cancers are treated with immunotherapy like Pembrolizumab and Nivolumab. Personalized cancer treatment insights.